BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 989406)

  • 1. [Antipsychotic efficacy in relation to plasma levels of clozapine (author's transl)].
    Ackenheil M; Bräu H; Burkhart A; Franke A; Pacha W
    Arzneimittelforschung; 1976; 26(6):1156-8. PubMed ID: 989406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Relationships between effects and plasma levels of clozapine (author's transl)].
    Bräu H; Burkhart A; Pacha W; Ackenheil M
    Arzneimittelforschung; 1978; 28(8):1300. PubMed ID: 582391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment outcome with clozapine in tardive dyskinesia, neuroleptic sensitivity, and treatment-resistant psychosis.
    Small JG; Milstein V; Marhenke JD; Hall DD; Kellams JJ
    J Clin Psychiatry; 1987 Jul; 48(7):263-7. PubMed ID: 2885310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of phenytoin on plasma clozapine concentrations in two patients.
    Miller DD
    J Clin Psychiatry; 1991 Jan; 52(1):23-5. PubMed ID: 1988414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma clozapine levels and clinical response in treatment-refractory Chinese schizophrenic patients.
    Wong JO; Leung SP; Mak T; Ng RM; Chan KT; Hon-Kee Cheung H; Choi WK; Lai J; Wai-Kiu Tsang A
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):251-64. PubMed ID: 16316716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clozapine and metabolites: concentrations in serum and clinical findings during treatment of chronically psychotic patients.
    Centorrino F; Baldessarini RJ; Kando JC; Frankenburg FR; Volpicelli SA; Flood JG
    J Clin Psychopharmacol; 1994 Apr; 14(2):119-25. PubMed ID: 8195452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clozapine: guidelines for clinical management.
    Lieberman JA; Kane JM; Johns CA
    J Clin Psychiatry; 1989 Sep; 50(9):329-38. PubMed ID: 2670914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clozapine in the treatment of mental manifestations of Parkinson disease].
    Diederich N; Keipes M; Graas M; Metz H
    Rev Neurol (Paris); 1995 Apr; 151(4):251-7. PubMed ID: 7481376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on side-effects in treatment of psychoses with clozapine (Leponex)].
    Kirkegaard A; Jensen A
    Ugeskr Laeger; 1977 Nov; 139(47):2800-5. PubMed ID: 595167
    [No Abstract]   [Full Text] [Related]  

  • 10. [Relationship between clozapine plasma levels and withdrawal symptoms].
    Berecz R; de la Rubia Martínez A; Norberto Gamero MJ; Gutiérrez Casares JR; Glaub T; Degrell I; Llerena A
    Actas Esp Psiquiatr; 2002; 30(6):397-9. PubMed ID: 12487951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High plasma clozapine levels in tardive dyskinesia.
    Pollack S; Lieberman J; Kleiner D; Szymanski S; Kane J; Borenstein M; Cooper T
    Psychopharmacol Bull; 1993; 29(2):257-62. PubMed ID: 8290674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clozapine-induced electroencephalogram changes as a function of clozapine serum levels.
    Freudenreich O; Weiner RD; McEvoy JP
    Biol Psychiatry; 1997 Jul; 42(2):132-7. PubMed ID: 9209730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of manic psychosis with clozapine (author's transl)].
    Müller P; Heipertz R
    Fortschr Neurol Psychiatr Grenzgeb; 1977 Jul; 45(7):420-4. PubMed ID: 587099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerability and efficacy of clozapine combined with lithium in schizophrenia and schizoaffective disorder.
    Small JG; Klapper MH; Malloy FW; Steadman TM
    J Clin Psychopharmacol; 2003 Jun; 23(3):223-8. PubMed ID: 12826983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clozapine in the treatment of adverse psychiatric manifestations of long-term therapy with levodopa].
    Svetel MV; Sternić NM; Filipović SR; Vojvodić NM; Kostić VS
    Srp Arh Celok Lek; 1997; 125(7-8):203-6. PubMed ID: 9304232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of clozapine on sleep in bipolar and schizoaffective disorders.
    Armitage R; Cole D; Suppes T; Ozcan ME
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Nov; 28(7):1065-70. PubMed ID: 15610918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clozapine: an atypical antipsychotic agent.
    Ereshefsky L; Watanabe MD; Tran-Johnson TK
    Clin Pharm; 1989 Oct; 8(10):691-709. PubMed ID: 2572373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omeprazole reduces clozapine plasma concentrations. A case report.
    Frick A; Kopitz J; Bergemann N
    Pharmacopsychiatry; 2003 May; 36(3):121-3. PubMed ID: 12806570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent use of clozapine and valproate in affective and psychotic disorders.
    Kando JC; Tohen M; Castillo J; Centorrino F
    J Clin Psychiatry; 1994 Jun; 55(6):255-7. PubMed ID: 8071281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropsychological effects of maintenance treatment with Clozapine in Treatment-Resistant Psychotic Disorder.
    Carceller-Sindreu M; Portella MJ; Carmona C; Rametti G; Puigdemont D; Figueras M; Fernández-Vidal A; Villalta L; Alvarez E
    Actas Esp Psiquiatr; 2014; 42(2):68-73. PubMed ID: 24715364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.